Dose-escalated Simultaneous Integrated Boost Radiotherapy in Early Breast Cancer (IMPORT HIGH): a Multicentre, Phase 3, Non-Inferiority, Open-Label, Randomised Controlled Trial.

Lancet(2023)

引用 3|浏览61
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要